Meticulous Research®, a global leader in market research, has released its latest report on the High Throughput Screening (HTS) Market. According to the report, the global HTS market is projected to reach $47.41 billion by 2031, growing at a robust CAGR of 10.1% from 2024 to 2031. This growth trajectory reflects the increasing adoption of innovative HTS technologies, expanded funding for drug discovery, and the rising number of HTS facilities worldwide.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3206
Market Drivers and Challenges
The HTS market is poised for significant growth due to several key factors. Pharmaceutical and biotechnology companies are increasingly adopting innovative HTS methods, such as cell-based assays, label-free technologies, and lab-on-chip solutions. Additionally, heightened funding for drug discovery and an expanding array of drug targets are contributing to market expansion. However, challenges such as high capital investment requirements and evolving government regulations for drug development may temper growth.
Technological advancements, including multiplexed HTS assays, miniaturization techniques, AI integration, ultra-high-throughput screening (uHTS), and organ-on-chip technologies, are expected to drive future market opportunities. Despite this, complexities in HTS data management and the potential for false positive results remain significant hurdles.
Key Market Segments
The report segments the HTS market by technology, offering, application, end user, and geography:
• Technology: Cell-Based Assays (2D, 3D, Perfusion), Label-Free, Ultra High Throughput Screening, Lab-On-Chip
• Offering: Consumables & Reagents, Instruments (Sample Preparation, Liquid Handling, Readers), Software & Services
• Application: Stem Cell Research, Toxicology Assessment, Target Identification, Primary Screening
• End User: Pharmaceuticals & Biotechnology Industry, Academics & Research Institutes, Contract Research Organizations
• Geography: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
In 2024, the consumables and reagents segment is anticipated to dominate the market due to advancements in kit development and their recurrent applications. Among technologies, cell-based assays are expected to hold the largest market share, with 3D cell cultures projected to exhibit the highest CAGR. The target identification application will lead the market, driven by increased drug development needs and rising costs associated with drug discovery.
Regional Insights
Geographically, Asia-Pacific is forecasted to experience the highest CAGR during the forecast period, with China leading the growth. The surge in pharmaceutical R&D spending in China, exemplified by a 12.4% increase in spending by BeiGene Ltd. in 2022, is positively influencing HTS market expansion. Moreover, the significant rise in drug discoveries and investigational new drug applications (INDs) in China further underscores the region’s pivotal role in the market.
Leading Players
Key players in the global HTS market include:
• Thermo Fisher Scientific, Inc. (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Merck KGaA (Germany)
• Danaher Corporation (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Revvity Inc. (U.S.)
• Tecan Group Ltd. (Switzerland)
• Axxam S.p.A. (Italy)
• Charles River Laboratories International, Inc. (U.S.)
• Hamilton Company (U.S.)
• Promega Corporation (U.S.)
• Aurora Biomed Inc. (Canada)
Quick Buy @ https://www.meticulousresearch.com/Checkout/82641893
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research